DSY.PA

$17.96-0.15 (-0.83%)

Market OpenAs of Mar 18, 8:07 AM UTC

Dassault Systèmes SE provides software solutions and services worldwide.

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

Simply Wall St.
Mar 13, 2026

Assessing Dassault Systèmes (ENXTPA:DSY) Valuation After New MODS Inc. Modular Housing Partnership

Dassault Systèmes (ENXTPA:DSY) drew fresh investor attention after MODS Inc. agreed to use its virtual twin and 3DEXPERIENCE platform across modular housing projects, including a committed pipeline of €500 million equivalent in construction work. See our latest analysis for Dassault Systèmes. Despite the MODS and Medidata announcements highlighting fresh use cases for its platforms, Dassault Systèmes’ 1-month share price return of 4.08% sits against a much weaker year-to-date share price...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 5, 2026

Assessing Dassault Systèmes (ENXTPA:DSY) After A 53% One-Year Share Price Drop

If you are wondering whether Dassault Systèmes shares are starting to look interesting at current levels, this article walks through what the numbers are actually saying about value. The stock last closed at €18.18, with returns of 0.8% over the past week, a 21.6% decline over 30 days, a 22.3% decline year to date, and a 53.3% decline over the past year. These moves come as investors keep a close eye on Dassault Systèmes as a large European software name, where sentiment can swing quickly...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 5, 2026

Dassault Systèmes Deepens AI Role In Drug Development And Manufacturing

Medidata, a Dassault Systèmes (ENXTPA:DSY) brand, received top innovation ratings for its AI driven clinical trial solutions and a Luminary designation for its role in FDA novel drug approvals. Medidata’s AI platforms are used across a large share of FDA novel drug approvals, supporting trial efficiencies and digital workflows in clinical research. Dassault Systèmes expanded its healthcare footprint through a new collaboration between Medidata and CRIO focused on clinical data...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 4, 2026

Dassault and Airbus are Turning FCAS Into a Public Spat

Dassault CEO Eric Trappier says the next-generation fighter needs one clear leader, and he is done pretending the fight is about engineering

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Moby
Mar 4, 2026

Dassault and Airbus Turn Europe’s Next Fighter Jet Into a Public Spat

Dassault CEO Eric Trappier says the next-generation fighter needs one clear leader, and he is done pretending the fight is about engineering

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.